Global market size-
According to the new market research report Interventional Cardiology Market size is projected to reach $21.2 billion by 2025, at a CAGR of 8.9%.
Leading Players-
Some of the major players in the interventional cardiology devices market include Medtronic (US), Boston Scientific Corporation (US), Abbott (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Cardinal Health (US), iVascular (Spain), Edward Lifescinces Corporation (US), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).
Boston Scientific is the leading player in the interventional cardiology devices market. The company offers a wide range of guidewires, stents, catheters, angioplasty balloons, and structural heart devices. In the last three years, the company has been focusing on expanding its interventional cardiology portfolio by adopting various organic and inorganic strategies. Apart from this, the company has a strong presence in the US. As a result, in 2019, the company registered ~46% of its total interventional cardiology revenue from the US alone.
Top Segments-
Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.
Based on type, the catheters market is categorized into angiography catheters, guiding catheters, and IVUS/OCT catheters. Among all the angiography catheters segment accounted for the largest share of the catheters market in 2019. This is due to the high and increasing prevalence of coronary artery diseases (CAD), coupled with the growing awareness about the benefits of the early diagnosis of CADs.
For More Details, Download PDF Brochure
Geographic Overview -
North America accounted for the largest share of the interventional cardiology market in 2019. The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the growing geriatric population, and the strong presence of industry players in the region.